Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Drug Targets ; 22(11): 1317-1331, 2021.
Article in English | MEDLINE | ID: mdl-33461463

ABSTRACT

The regulatory mechanisms lying over the genome that determines the differential expression of genes are termed epigenetic mechanisms. DNA methylation, acetylation, and phosphorylation of histone proteins and RNAi are typical examples. These epigenetic modifications are important determinants of normal growth and metabolism; at the same time, aberrant histone modifications play a major role in pathological conditions and are emerging as a new area of research for the last decades. Histone onco-modification is a term introduced by the scientific world to denote histone post-translational modifications that are associated with cancer development and progression. These modifications are likely to act in certain conditions as adaptive mechanisms to environmental and social factors. The enzymes that regulate DNA methylation as well as histone modifications are thus become a target for cancer therapy and chemoprevention. Since oxidative stress has been shown to modulate epigenetic changes, and phytocompounds with powerful antioxidant properties have a significant role in disease prevention. Nowadays, "nutri- epigenetics" is becoming an emerging area of research that deals with the influence of dietary compounds in epigenetics. This review aims to discuss the biological efficacy of promising phytocompounds that are able to counteract deleterious epigenetic modifications, especially histone onco- modifications.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Histones , Neoplasms , Protein Processing, Post-Translational , Acetylation , DNA Methylation , Epigenesis, Genetic , Histone Code , Histones/metabolism , Humans , Neoplasms/drug therapy , Neoplasms/genetics
2.
Recent Pat Anticancer Drug Discov ; 12(3): 234-246, 2017.
Article in English | MEDLINE | ID: mdl-28440207

ABSTRACT

BACKGROUND: Epithelial-Mesenchymal Transition (EMT) is the conversion of epithelial cells into mesenchymal phenotype generally observed during embryogenesis and wound healing as well as in malignant transformation. Several signaling pathways and transcription factors associated with EMT have been explored. Dietary phytochemicals that are multi-targeted agents which interfere with these pathways, assume preventive potential against pathologic EMT. OBJECTIVE: The present review aims to provide a detailed description of the nature and characteristics of EMT in physiological and pathophysiological conditions and the scope of phytochemicals in its prevention. METHOD: Details regarding the initiation, progression as well as prevention of pathologic EMT and metastasis and recent patents on preventive phytochemicals were obtained from PubMed literatures and patent databases. RESULTS: The phenotypic changes during EMT are regulated by transcription factors like Snail, Slug, Twist and Zeb, which are activated through diverse signaling pathways of TGF-ß, NF-kB, Wnt and Notch. s phytocompounds that are potent enough to interfere with these signaling pathways, which in turn prevent pathological implications of EMT. Present review also discusses 28 recent patents on those phytocompounds. CONCLUSION: EMT is a significant pharmacological target for developing preventive agents to combat pathological conditions like malignancy. Many of the phytochemicals cited in this review are being enrolled for different phases of clinical trials for their efficacy. In spite of the major limitations regarding bioavailability, sensitivity and tolerance of these compounds, their synthetic analogs, formulations and efficient drug delivery systems are also being attempted which will hopefully generate productive and promising results in near future.


Subject(s)
Epithelial-Mesenchymal Transition/drug effects , Neoplasms/drug therapy , Neoplasms/prevention & control , Phytochemicals/pharmacology , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/pharmacology , Disease Progression , Drug Delivery Systems , Humans , Molecular Targeted Therapy , Patents as Topic , Phytochemicals/administration & dosage , Signal Transduction/drug effects
3.
Toxicol Mech Methods ; 27(3): 207-214, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27996366

ABSTRACT

Omega-3 fatty acids are well-known class of nutraceuticals with established health benefits. Recently, the oxidation products of these fatty acids are gaining attention, as they are likely to disturb body redox balance. Therefore, the efficacy of omega-3 fats under conditions of diminished antioxidant status, such as aging, is always a concern. Present study assessed the effects of omega-3 fats (DHA and EPA) together with or without vitamin-E in naturally aged rats. It was found that in omega-3 fats alone consumed rats the lipid profile was improved, while in omega-3 fat with vitamin-E-consumed group (OMVE), the hepato protective and antioxidant properties were pronounced, especially the redox status of brain tissue. It is possible that vitamin-E might have reduced the peroxidation of omega-3 fats, thereby allowing their synergistic effects. Hence, the use of vitamin-E along with omega-3 fat may be beneficial under aged conditions.


Subject(s)
Aging/metabolism , Antioxidants/pharmacology , Fatty Acids, Omega-3/pharmacology , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Vitamin E/pharmacology , Animals , Antioxidants/administration & dosage , Behavior, Animal/drug effects , Body Weight/drug effects , Brain/drug effects , Brain/metabolism , Drug Synergism , Fatty Acids, Omega-3/administration & dosage , Male , Rats, Wistar , Vitamin E/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...